244 related articles for article (PubMed ID: 26118988)
1. Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 - 2014).
Tsai YF; Hwang TL
Expert Opin Ther Pat; 2015; 25(10):1145-58. PubMed ID: 26118988
[TBL] [Abstract][Full Text] [Related]
2. A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications.
Crocetti L; Quinn MT; Schepetkin IA; Giovannoni MP
Expert Opin Ther Pat; 2019 Jul; 29(7):555-578. PubMed ID: 31204543
[TBL] [Abstract][Full Text] [Related]
3. The Role of Neutrophil Elastase Inhibitors in Lung Diseases.
Polverino E; Rosales-Mayor E; Dale GE; Dembowsky K; Torres A
Chest; 2017 Aug; 152(2):249-262. PubMed ID: 28442313
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease).
Roghanian A; Sallenave JM
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):125-44. PubMed ID: 18518838
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores.
von Nussbaum F; Li VM
Bioorg Med Chem Lett; 2015 Oct; 25(20):4370-81. PubMed ID: 26358162
[TBL] [Abstract][Full Text] [Related]
6. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.
Bingle L; Tetley TD
Thorax; 1996 Dec; 51(12):1273-4. PubMed ID: 8994529
[TBL] [Abstract][Full Text] [Related]
7. Novel neutrophil elastase inhibitors as a treatment for neutrophil-predominant inflammatory lung diseases.
Ohbayashi H
IDrugs; 2002 Sep; 5(9):910-23. PubMed ID: 12800053
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
9. Potential role of inhibitors of neutrophil elastase in treating diseases of the airway.
Chughtai B; O'Riordan TG
J Aerosol Med; 2004; 17(4):289-98. PubMed ID: 15684729
[TBL] [Abstract][Full Text] [Related]
10. AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase.
Stevens T; Ekholm K; Gränse M; Lindahl M; Kozma V; Jungar C; Ottosson T; Falk-Håkansson H; Churg A; Wright JL; Lal H; Sanfridson A
J Pharmacol Exp Ther; 2011 Oct; 339(1):313-20. PubMed ID: 21791628
[TBL] [Abstract][Full Text] [Related]
11. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
[TBL] [Abstract][Full Text] [Related]
12. Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases.
Chu X; Sun Z; Baek DS; Li W; Mellors JW; Shapiro SD; Dimitrov DS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681796
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of neutrophil elastase inhibitors.
Tremblay GM; Janelle MF; Bourbonnais Y
Curr Opin Investig Drugs; 2003 May; 4(5):556-65. PubMed ID: 12833649
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of benzoxazinone derivatives on activity of human neutrophil elastase and on hemorrhagic shock-induced lung injury in rats.
Hsieh PW; Yu HP; Chang YJ; Hwang TL
Eur J Med Chem; 2010 Jul; 45(7):3111-5. PubMed ID: 20417587
[TBL] [Abstract][Full Text] [Related]
15. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
[TBL] [Abstract][Full Text] [Related]
16. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
[TBL] [Abstract][Full Text] [Related]
17. Targeting neutrophil elastase in cystic fibrosis.
Kelly E; Greene CM; McElvaney NG
Expert Opin Ther Targets; 2008 Feb; 12(2):145-57. PubMed ID: 18208364
[TBL] [Abstract][Full Text] [Related]
18. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
[TBL] [Abstract][Full Text] [Related]
19. Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases.
von Nussbaum F; Li VM; Allerheiligen S; Anlauf S; Bärfacker L; Bechem M; Delbeck M; Fitzgerald MF; Gerisch M; Gielen-Haertwig H; Haning H; Karthaus D; Lang D; Lustig K; Meibom D; Mittendorf J; Rosentreter U; Schäfer M; Schäfer S; Schamberger J; Telan LA; Tersteegen A
ChemMedChem; 2015 Jul; 10(7):1163-73. PubMed ID: 26083237
[TBL] [Abstract][Full Text] [Related]
20. N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.
Craciun I; Fenner AM; Kerns RJ
Glycobiology; 2016 Jul; 26(7):701-709. PubMed ID: 26850997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]